Literature DB >> 11006255

Elevation of vitreous leptin in diabetic retinopathy and retinal detachment.

R F Gariano1, A K Nath, D J D'Amico, T Lee, M R Sierra-Honigmann.   

Abstract

PURPOSE: Leptin is a cytokine that regulates energy metabolism and is linked to diabetes mellitus through its metabolic actions. Leptin is angiogenic and promotes wound healing, and therefore this investigation was conducted to determine whether leptin is associated with neovascular and fibrotic complications of diabetes and other retinopathies.
METHODS: Serum and vitreous samples were collected from patients classified by the presence and type of diabetic retinopathy or other ocular diseases. Leptin was measured in serum and vitreous by radioimmunoassay, and leptin and leptin receptor were localized in epiretinal membranes immunohistochemically.
RESULTS: Leptin levels in serum and vitreous were higher in patients with diabetes than in those without, and vitreous leptin concentrations were especially elevated in patients with proliferative diabetic retinopathy or retinal detachment. Leptin and leptin receptor were detected in fibrovascular epiretinal membrane of patients with diabetes.
CONCLUSIONS: Leptin in human vitreous is elevated in proliferative diabetic retinopathy, and retinal detachment and is present in fibrovascular epiretinal tissue. These data suggest an involvement of leptin in retinal disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11006255

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  22 in total

1.  The unfolding tale of leptin.

Authors:  H Jeet Singh
Journal:  Malays J Med Sci       Date:  2001-07

2.  Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice.

Authors:  Neeraj K Saxena; Kazuo Ikeda; Don C Rockey; Scott L Friedman; Frank A Anania
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

3.  Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy.

Authors:  Makiko Katagiri; Jun Shoji; Noriko Inada; Satoshi Kato; Shigehiko Kitano; Yasuko Uchigata
Journal:  Int Ophthalmol       Date:  2017-03-15       Impact factor: 2.031

Review 4.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

Review 5.  Leptin in the field of hepatic fibrosis: a pivotal or an incidental player?

Authors:  Sotirios K Bethanis; Stamatios E Theocharis
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

Review 6.  Obesity and eye diseases.

Authors:  Ning Cheung; Tien Y Wong
Journal:  Surv Ophthalmol       Date:  2007 Mar-Apr       Impact factor: 6.048

7.  Leptin activates the JAK/STAT pathway to promote angiogenesis in RF/6A cells in vitro.

Authors:  Le Zhang; Rong Li; Bing-Hui Wu; Ting-Ting Liang; Zhe Liu; Wei Ju; Yi Wang; Yu-Ting Wen; Ming-Cui Liu; Jun-Hui Du
Journal:  Int J Ophthalmol       Date:  2022-04-18       Impact factor: 1.779

8.  Activated VEGF receptor shed into the vitreous in eyes with wet AMD: a new class of biomarkers in the vitreous with potential for predicting the treatment timing and monitoring response.

Authors:  Geetanjali Davuluri; Virginia Espina; Emanuel F Petricoin; Mark Ross; Jianghong Deng; Lance A Liotta; Bert M Glaser
Journal:  Arch Ophthalmol       Date:  2009-05

9.  Obesity-associated hyperleptinemia alters the gliovascular interface of the hypothalamus to promote hypertension.

Authors:  Tim Gruber; Chenchen Pan; Raian E Contreras; Tobias Wiedemann; Donald A Morgan; Alicja A Skowronski; Sandrine Lefort; Cahuê De Bernardis Murat; Ophelia Le Thuc; Beata Legutko; Francisco J Ruiz-Ojeda; María de la Fuente-Fernández; Angel Luis García-Villalón; Daniel González-Hedström; Melanie Huber; Klara Szigeti-Buck; Timo D Müller; Siegfried Ussar; Paul Pfluger; Steve C Woods; Ali Ertürk; Charles A LeDuc; Kamal Rahmouni; Miriam Granado; Tamas L Horvath; Matthias H Tschöp; Cristina García-Cáceres
Journal:  Cell Metab       Date:  2021-05-04       Impact factor: 27.287

10.  PEDF in diabetic retinopathy: a protective effect of oxidative stress.

Authors:  Xiao-feng Zhu; Hai-dong Zou
Journal:  J Biomed Biotechnol       Date:  2012-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.